| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
ReNeuron CFO to depart in May
StockMarketWire.com
|
Therapeutics development firm ReNeuron has announced that Michael Hunt, executive director and chief financial officer, yesterday resigned from the company in order to pursue other projects.
Mr Hunt commented: "After twenty years at the company, and with the business now in a much stronger financial position, it is the right time for me to move on to new challenges.
I am proud to have contributed to ReNeuron's progression to be one of the leading players in the gene and cell therapy sector, and I wish the Company and colleagues every future success."
He will remain with the company until the end of May to facilitate an orderly transition to his successor, for whom a search has been initiated.
Olav Hellebų, chief executive officer, said: "With tenures over the years as both CFO and CEO of the company, Michael has played a key role in the development of ReNeuron into the exciting business that it is today.
On behalf of ReNeuron, I would like to thank Michael for his very significant contribution to the Company and wish him well in his future endeavours."
Story provided by StockMarketWire.com
|
|
|
|
|
|
